NCT05730920View on ClinicalTrials.gov

IV Methadone Vs EXPAREL Erector Spinae Plane Blockade in Pediatric Subjects Undergoing Idiopathic Scoliosis Correction

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

July 16, 2024

Study Completion Date

September 21, 2024

Conditions
Adolescent Idiopathic ScoliosisJuvenile Idiopathic Scoliosis
Interventions
DRUG

Methadone

IV Methadone

DRUG

Liposomal bupivacaine (LB, Exparel)

LB and bupivacaine hydrochloride via erector spinae plane blocks

Trial Locations (1)

95817

Shriners Hospitals for Children, Sacramento

Sponsors
All Listed Sponsors
collaborator

Pacira Pharmaceuticals, Inc

INDUSTRY

lead

Dr. Casey Stondell, MD

OTHER

NCT05730920 - IV Methadone Vs EXPAREL Erector Spinae Plane Blockade in Pediatric Subjects Undergoing Idiopathic Scoliosis Correction | Biotech Hunter | Biotech Hunter